Kyverna Therapeutics, Inc. Common Stock (KYTX)
Kyverna Therapeutics, Inc. Common Stock (KYTX) has reported earnings 10 times since Mar 26, 2024. The stock moves an average of ±7.64% the day after reporting, closing higher 40.0% of the time. Its largest post-earnings gain was +15.67% (Aug 12, 2025) and its largest decline was -15.25% (Mar 27, 2025). The next earnings report is predicted for 2026-08-12 (estimated).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
10
Avg Abs. Movement
±7.64%
Positive %
40.0%
Negative %
60.0%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| May 12, 2026 | ☽ POST | $10.21 | $10.27 | $10.23 | 36,759 | +5.28% | open_in_new |
| Mar 26, 2026 | ☽ POST | $8.14 | $8.35 | $8.01 | 33,382 | -2.5% | open_in_new |
| Nov 12, 2025 | ☽ POST | $7.20 | $7.40 | $7.33 | 28,821 | -11.6% | open_in_new |
| Aug 12, 2025 | ☽ POST | $3.07 | $3.08 | $3.00 | 25,393 | +15.67% | open_in_new |
| May 13, 2025 | ☽ POST | $2.23 | $2.32 | $2.32 | 12,080 | -8.62% | open_in_new |
| Mar 27, 2025 | ☽ POST | $2.57 | $2.57 | $2.36 | 19,295 | -15.25% | open_in_new |
| Nov 13, 2024 | ☽ POST | $5.18 | $5.33 | $5.07 | 6,199 | -4.73% | open_in_new |
| Aug 12, 2024 | ☽ POST | $6.54 | $6.88 | $6.51 | 25,432 | +7.53% | open_in_new |
| May 14, 2024 | ☽ POST | $14.98 | $15.72 | $15.48 | 8,082 | +2.49% | open_in_new |
| Mar 26, 2024 | ☽ POST | $23.82 | $24.85 | $24.85 | 90,986 | -2.74% | open_in_new |
Earnings Count
10
Total earnings in dataset
Avg Abs. Movement
±7.64%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
9 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| 8-K | 20260602 | open_in_new SEC.gov |
| 4 | 20260529 | open_in_new SEC.gov |
| 4 | 20260529 | open_in_new SEC.gov |
| 4 | 20260529 | open_in_new SEC.gov |
| 4 | 20260529 | open_in_new SEC.gov |
| 4 | 20260529 | open_in_new SEC.gov |
| 3 | 20260520 | open_in_new SEC.gov |
| 4 | 20260520 | open_in_new SEC.gov |
| 8-K | 20260518 | open_in_new SEC.gov |
Frequently asked about KYTX earnings
When does Kyverna Therapeutics, Inc. Common Stock report earnings next? expand_more
Kyverna Therapeutics, Inc. Common Stock (KYTX)'s next earnings date is estimated for 2026-08-12. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does KYTX stock move after earnings? expand_more
Over 10 reports, KYTX has moved an average of ±7.64% the session after earnings, closing higher 40.0% of the time.
What was KYTX's biggest post-earnings move? expand_more
KYTX's largest post-earnings gain on record was +15.67% on Aug 12, 2025, and its largest decline was -15.25% on Mar 27, 2025.
Where can I find Kyverna Therapeutics, Inc. Common Stock's SEC filings? expand_more
All of Kyverna Therapeutics, Inc. Common Stock's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right